A Lesson to Learn o...
Health Care: Drugs
Johnson & Johnson (JNJ: NYSE)
$86.36 0.73 | 0.85%
06/18/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with JNJ
- Portfolio NameUser Type
- ContributorHigh Volume Technicals for ...
- UserSlip's Portfolio
- Userralphd5-2013
- ContributorHigh Volume Technicals for ...
- ProGeorge Soros
- UserQuicksilver55
- UserDC
- ContributorStocks Fund Managers Love Q...
- ContributorGame of Thrones Portfolio
- UserCapt Jer
Latest JNJ Headlines from TheStreet
- Johnson & Johnson Gets Key Cancer Drug With Aragon Buy 06.18.13 | 11:06 am
- Buy-Rated Dow Components Slips To Ten 06.18.13 | 08:06 am
- 5 Stocks Raising The Drugs Industry Higher 06.17.13 | 01:06 pm
- J&J Buy of Aragon Deals a Blow To Medivation 06.17.13 | 09:06 am
- 5 Big Trades for a Ping-Pong Market 06.13.13 | 06:06 am
- Johnson & Johnson (JNJ): Today's Featured Drugs Laggard 06.12.13 | 05:06 pm
- Some Top Funds Are Dumping Bonds 06.12.13 | 08:06 am
- 5 Drugs Stocks On The Rise 06.10.13 | 01:06 pm
- Charge into Visa, T. Rowe
06.05.13 | 04:06 pm - CELG, AMGN, GILD, JNJ And PFE, Pushing Drugs Industry Downward 06.04.13 | 01:06 pm
Press Releases for JNJ
- Johnson & Johnson Announces Sale Of Elan American Depositary Shares To Elan - PR Newswire 04.18.13 | 09:04 am
- Johnson & Johnson To Webcast Annual Meeting Of Shareholders - PR Newswire 04.11.13 | 07:04 am
- Look And Feel Great This Spring, Despite Allergy Symptoms - PR Newswire 04.09.13 | 07:04 am
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Johnson & Johnson To Host Analyst Conference Call On First-Quarter Results - PR Newswire 03.19.13 | 10:03 am
- Cordis Acquires Flexible Stenting Solutions, Inc. - Business Wire 03.12.13 | 09:03 am
- Johnson & Johnson Comments On Venezuelan Currency Devaluation - PR Newswire 02.25.13 | 07:02 am
- Johnson & Johnson To Participate In 2013 Citi Global Health Care Conference - PR Newswire 02.20.13 | 09:02 am
- Johnson & Johnson To Participate In 2013 Leerink Swann Global Health Care Conference - PR Newswire 02.06.13 | 10:02 am
- Johnson & Johnson Presents Growth Strategies For Medical Devices & Diagnostics Segment - PR Newswire 01.22.13 | 09:01 am
Partner Headlines for JNJ
- Companies slide $181B through tax loopholes - MSN Money 04.19.13 | 10:04 am
- Protect Yourself From Gold - Seeking Alpha 04.19.13 | 08:04 am
- Market Close Report: NASDAQ Composite index closes at 3,204.67 down -59.96 points - NASDAQ 04.17.13 | 08:04 pm
- Abbott Labs' Q1 Earnings Steady After AbbVie Spinoff - Investor's Business Daily 04.17.13 | 04:04 pm
- Questcor Pharmaceuticals, Inc. (QCOR) Ex-Dividend Date Scheduled for April 18, 2013 - NASDAQ 04.17.13 | 01:04 pm
- Dow up 158 as stocks stage a 'never-mind' rally - MSN Money 04.17.13 | 11:04 am
- The Dip's Been Bought, Now Prepare Or Despair - Seeking Alpha 04.17.13 | 09:04 am
- US corporate earnings boost Wall St - Financial Times 04.16.13 | 09:04 pm
- Biotech Alkermes Poised To Swell On Pipeline Wins - Investor's Business Daily 04.16.13 | 05:04 pm
- J&J Q1 Earnings Beat; Pharma Strong, Devices Weak - Investor's Business Daily 04.16.13 | 04:04 pm
